Drug Use Investigation for HEPSERA (Adefovir) Tablet

• Status: Completed
• Trial end date: 2012-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This post-marketing surveillance (PMS) is conducted to collect safety and efficacy data among subjects with chronic hepatitis B and hepatic cirrhosis B who is treated with adefovir tablets.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Adefovir; Adefovir dipivoxil

Criteria

Inclusion Criteria:

• Subjects with chronic hepatitis B or hepatic cirrhosis B

• Subjects treated with adefovir tablets

Exclusion Criteria:

• None